Premature clinical trial discontinuation in the era of immune checkpoint inhibitors

Premature clinical trial discontinuation in the era of immune checkpoint inhibitors

El texto completo de este trabajo no está disponible en el Repositorio Académico UPC por restricciones de la casa editorial donde ha sido publicado. === Background: Clinical trial completion is critical for new cancer therapies. Premature trial termination or withdrawal is common and impairs progres...

Full description

Bibliographic Details
Main Authors: Khunger, Monica, Rakshit, Sagar, Hernandez, Adrian V., Pasupuleti, Vinay, Glass, Kate, Galsky, Matthew D., Grivas, Petros
Other Authors: pgrivas@uw.edu
Format: Article
Language:English
Published: Wiley-Blackwell 2018
Subjects:
Cancer
Clinical trial termination
Immune checkpoint inhibitors
Immunotherapy
Online Access:http://hdl.handle.net/10757/624716

Internet

http://hdl.handle.net/10757/624716

Similar Items